Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study.
about
Prognostic factors for risk stratification of adult cancer patients with chemotherapy-induced febrile neutropenia: a systematic review and meta-analysis.Management of febrile neutropenia: ESMO Clinical Practice Guidelines.Outpatient management of cancer patients with febrile neutropenia: a systematic review and meta-analysis.A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findingsCost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients.Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaeniaThe evolution towards ambulatory and day-case management of febrile neutropenia.Management of febrile neutropenia in the United Kingdom: time for a national trial?Empiric therapy for febrile neutropenia: what are the choices?Safety of early discharge for low-risk patients with febrile neutropenia: a multicenter randomized controlled trial.Etiology and clinical course of febrile neutropenia in children with cancer.Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia.The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients.Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.The time has come for new models in febrile neutropenia: a practical demonstration of the inadequacy of the MASCC score.Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.Piperacillin/tazobactam vs. cefoperazone/sulbactam in adult low-risk febrile neutropenia cases.Feasibility of early discharge strategies for neutropenic fever: outcomes of a Victorian organisational readiness assessment and pilot.Early discharge and ambulatory care of low-risk patients with neutropenic fever in Australia.Eliciting patients' preferences for outpatient treatment of febrile neutropenia: a discrete choice experiment.Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients.Use of risk stratification to guide ambulatory management of neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee.Chemotherapy outpatients' unplanned presentations to hospital: a retrospective study.Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.Treatment of febrile neutropenia is expensive: prevention is the answer.Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.Report on outpatient management of patients with neutropenic fever in a tertiary hospital.
P2860
Q33412051-CEEBC12D-7708-40CA-8A4E-720308E87867Q34620670-DAC3A269-7E7B-4CC2-82EF-DE45AB69FF28Q34627284-9339D64D-7DC8-4EC0-BBF4-65B2DDB90DECQ34627796-19185E2F-6D04-4575-9E25-E6E6E5386768Q35006851-EAC0C9C0-9BEC-4ED1-921C-F7DC02A81287Q35287551-DC4A9F03-0486-4AB6-BA49-0D2EAED355E1Q36573955-54763C5D-2C1D-4A8D-BA6D-4402EEFD32B7Q36614991-43BA35A7-7FE1-47A1-A598-8D0A94C072E6Q36839750-63258341-1737-4BC2-A685-2EAFCFDCC7DCQ36910461-9EFA50A0-0226-4EE5-BFEC-9B5095C33377Q37344556-E68F73E7-29BF-44EE-9AEF-382E08573AE9Q37921537-08B46717-4636-4ED9-BC3C-C8A335E3C14AQ37963923-D3288AA6-C78A-46B6-BF76-F9DD6177B790Q38084890-5384D6AF-DDB1-4650-B3BA-5BC196C61607Q38117578-D344B91B-0D5C-44CE-90E1-A5A679E8BD53Q38909993-1B68ECBE-4C60-4E36-8030-E887EA7E785DQ40041299-E54DC944-D060-47AE-8C0E-37AE735FA667Q40174792-708FF16E-E887-40FE-A392-D73E4ED4B977Q40222930-B52E1D1D-D579-4274-B1C7-BC82A14A5850Q40242847-439FC757-7AFA-468F-AB69-EEDFA0999807Q40248053-54726540-3BDF-44AD-9B1F-BA5E0236397CQ40284053-FC996FE8-7DF4-4FC9-A0B0-85767E78A65FQ40295657-6637A203-142D-43DF-84F9-60181E17D29BQ40335985-744E3ED2-69DF-4B15-A36B-B4B52C9EDF13Q40357920-64CE822D-7AC6-4F7A-A50A-D7D43A110F75Q40480821-30D491E0-6EB3-4B61-999B-005FCFCBB307Q42279456-26E98147-2005-499D-8752-63499533F75CQ43634166-ADE3C605-B4EB-456C-B43B-3AE4947CF757Q51617424-973B65EB-AEF6-43B3-BC1B-FE40F6C88561Q53081581-803F508F-49EB-4900-B5C8-295E3224511A
P2860
Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Oral antibiotics with early ho ...... ontrolled single centre study.
@ast
Oral antibiotics with early ho ...... ontrolled single centre study.
@en
type
label
Oral antibiotics with early ho ...... ontrolled single centre study.
@ast
Oral antibiotics with early ho ...... ontrolled single centre study.
@en
prefLabel
Oral antibiotics with early ho ...... ontrolled single centre study.
@ast
Oral antibiotics with early ho ...... ontrolled single centre study.
@en
P2093
P2860
P356
P1476
Oral antibiotics with early ho ...... ontrolled single centre study.
@en
P2093
P2860
P2888
P356
10.1038/SJ.BJC.6600993
P407
P577
2003-07-01T00:00:00Z